Bengaluru, Karnataka, India: October 31, 2023:
Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced it has once again solidified its standing as a premier employer by retaining its position amongst the Top 10 Employers in the global biotech, pharma and biopharma sector, at No. 8 in 2023. This coveted recognition bestowed by the prestigious U.S.-based Science magazine underscores Biocon’s key quality attributes such as an ‘innovative leader in the industry,’ being ‘socially responsible,’ and a company with ‘loyal employees.’
Employees across Biocon and Biocon Biologics participated in the annual Top 20 Employers Survey, which Science magazine has been conducting for over a decade to identify and celebrate the finest pharma and biotech companies. Biocon’s consistent presence on the Science Top Employers list of the world’s pre-eminent pharma, biotech, and biopharma employers for 11 consecutive years underlines its standing as an employer of choice.
The Biocon Group’s patient-centric approach resonates deeply with both its employees and potential candidates, contributing to its appeal as an employer. In addition to connecting with patients, Biocon and Biocon Biologics actively engage with physicians, nurses, and pharmacists to gain insights into how it can better serve these critical stakeholders. By studying the utilization and prescription of medications, Biocon and Biocon Biologics have successfully identified opportunities to reduce wastage, enhance operational efficiency, and lower costs. This multi-faceted problem-solving approach aligns closely with the academic ethos and is highly valued by STEM job candidates.
Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics, said: “We are delighted to be recognized once again amongst the Top 10 global biotech employers. We are extremely proud of the quality of talent we have nurtured at the Biocon Group. Our people are driven by the shared purpose of enabling ‘health equity’ and are committed to develop world class biopharmaceutical products. This recognition reflects our dedication towards enabling ‘people equity’ by creating an empowering and inclusive workplace where everyone gets an opportunity to advance their careers and be recognized and rewarded for their exemplary contributions.”
“This consistent recognition will motivate us to keep pushing the boundaries to create a highly thriving workplace culture that promotes unconventional thinking, focus on innovation, mutual respect, and collaboration. By empowering our people, we inculcate in them a strong spirit to stay the course even in the face of insurmountable challenges” she added.
In an interview with the Science magazine, Sandeep Athalye, Chief Development Officer, Biocon Biologics, said: “The purpose, vision, and patient centricity of Biocon and Biocon Biologics, resonates well with people and attracts a lot of talent. Our people are motivated to be innovative and approach the global problem of healthcare access with a lens of making medicines affordable and reachable to more people, while at the same time finding ways to make these therapies better for patients to use.”